Bill Text: NY A04571 | 2019-2020 | General Assembly | Introduced
Bill Title: Requires the brand name of a prescribed drug to be indicated on the label when substitute drug products are dispensed.
Spectrum: Moderate Partisan Bill (Republican 7-1)
Status: (Introduced - Dead) 2020-07-13 - held for consideration in consumer affairs and protection [A04571 Detail]
Download: New_York-2019-A04571-Introduced.html
STATE OF NEW YORK ________________________________________________________________________ 4571 2019-2020 Regular Sessions IN ASSEMBLY February 4, 2019 ___________ Introduced by M. of A. SMULLEN -- read once and referred to the Commit- tee on Consumer Affairs and Protection AN ACT to amend the education law, in relation to certain requirements when substitute drug products are dispensed The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph (c) of subdivision 1 of section 6816-a of the 2 education law, as added by chapter 776 of the laws of 1977, is amended 3 to read as follows: 4 (c) The pharmacist shall indicate on the label affixed to the immedi- 5 ate container in which the drug is sold or dispensed the name and 6 strength of the drug product and its manufacturer unless the prescriber 7 specifically states otherwise, and shall also indicate the brand name of 8 the drug prescribed. The pharmacist shall record on the prescription 9 form the brand name or the name of the manufacturer of the drug product 10 dispensed. 11 § 2. This act shall take effect on the thirtieth day after it shall 12 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD08703-01-9
